Ayurvedic medicines face EU ban from May 1

Vidya Ram London | Updated on February 03, 2011 Published on February 03, 2011


Practitioners of Ayurvedic and other traditional medicines in Europe are bracing themselves for a tough licensing system similar to that for Western medicines.

The EU's Traditional Herbal Medical Products Directive is set to come into effect on May 1, and requires any herbal medicine sold over the counter to have either a Traditional Herbal Registration or a marketing authorisation. The legislation is tantamount to a ban, as just 70-80 herbal products in the UK (none of which is Ayurvedic) have so far got the licence.

Mr Sebastian Pole, an Ayurvedic practitioner who runs Bristol-based firm Pukka Herbs with around 500 employees in India, said his company had been working on obtaining licences for six products at the cost of around £100,000. “It's a very onerous process and is going to have a very negative impact on all traditional medicines,” he told Business Line. “Yes, it's good to improve standards but this is like using a sledgehammer to crack a nut.”

Ayurvedic products account for around 5 per cent of the UK herbal medicine industry.

Dr Shantha Godagama, President, Ayurvedic Medical Association, who sits on the advisory board of the UK's Medicines and Health Care Products Regulatory Agency, said that while change and regulation were necessary in the long term to improve standards, in the short term it would merely reduce choice and hit the smallest firms the hardest. He said that in his time on the advisory committee, not a single application for a herbalist licence had been received.

“What we need to look at is whether there is a fault in the application system and whether it is too onerous,” he said. “In the short term, there is simply not going to be enough products to meet customer demand.”

Published on February 03, 2011

A letter from the Editor

Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.